Matches in Wikidata for { <http://www.wikidata.org/entity/Q66039380> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q66039380 description "assaig clínic" @default.
- Q66039380 description "clinical trial" @default.
- Q66039380 description "clinical trial" @default.
- Q66039380 description "clinical trial" @default.
- Q66039380 description "clinical trial" @default.
- Q66039380 description "ensaio clínico" @default.
- Q66039380 description "ensayo clínico" @default.
- Q66039380 description "ensayu clínicu" @default.
- Q66039380 description "essai clinique" @default.
- Q66039380 description "klinisch onderzoek" @default.
- Q66039380 description "клінічне випробування" @default.
- Q66039380 name "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 name "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 type Item @default.
- Q66039380 label "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 label "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 prefLabel "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 prefLabel "Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer" @default.
- Q66039380 P1132 Q66039380-AEF1E472-E9A6-40E4-811C-200C5C9E4CFE @default.
- Q66039380 P1476 Q66039380-988BFF4D-C47B-4E52-9856-627179DA374A @default.
- Q66039380 P17 Q66039380-5FAEBD63-40B1-4BD9-B831-17B35A243251 @default.
- Q66039380 P17 Q66039380-ADF029BB-8896-4E70-B7D0-C7F077807A38 @default.
- Q66039380 P17 Q66039380-B31792AC-030D-47D9-B70E-2A57527AC1BC @default.
- Q66039380 P17 Q66039380-B88E57A6-4D24-4B8D-ACF7-737E57E05E81 @default.
- Q66039380 P17 Q66039380-F14AE50B-F18F-46EC-BFE5-E23D763720C9 @default.
- Q66039380 P2899 Q66039380-7B37445A-D060-443D-85A6-F8F71FFB8372 @default.
- Q66039380 P3098 Q66039380-8DA3B09F-27F5-4F30-9986-EAB5169336DF @default.
- Q66039380 P31 Q66039380-9194238B-906C-431F-806C-92D8736FA61E @default.
- Q66039380 P4844 Q66039380-74219989-D9AD-4151-8E15-FB2DEF2B9CFD @default.
- Q66039380 P580 Q66039380-E69EF692-960E-4E56-8ADB-3DF2AF8C49E9 @default.
- Q66039380 P582 Q66039380-32A2DD5E-601E-460C-B1CB-11A9D195D380 @default.
- Q66039380 P6099 Q66039380-AADCB926-12DD-4AC7-9463-69C14D4E5544 @default.
- Q66039380 P8363 Q66039380-B0C2E6FF-08DA-4567-8261-793F7285D9C7 @default.
- Q66039380 P1132 "+121" @default.
- Q66039380 P1476 "A Randomised, Blinded, Phase 2 Study of Letrozole Plus the Farnesyl Transferase Inhibitor ZARNESTRA TM (R115777) and Letrozole Plus Placebo in the Treatment of Advanced Breast Cancer After Antiestrogen Therapy." @default.
- Q66039380 P17 Q142 @default.
- Q66039380 P17 Q145 @default.
- Q66039380 P17 Q30 @default.
- Q66039380 P17 Q31 @default.
- Q66039380 P17 Q55 @default.
- Q66039380 P2899 "+50" @default.
- Q66039380 P3098 "NCT00050141" @default.
- Q66039380 P31 Q30612 @default.
- Q66039380 P4844 Q7808830 @default.
- Q66039380 P580 "2002-09-01T00:00:00Z" @default.
- Q66039380 P582 "2005-10-01T00:00:00Z" @default.
- Q66039380 P6099 Q42824440 @default.
- Q66039380 P8363 Q78089383 @default.